Abstract:Stroke is the major cause of death and disability worldwide, and the thrombolytic therapy currently available was unsatisfactory. 14-3-3 epsilon is a well characterized member of 14-3-3 family, and has been reported to protect neurons against apoptosis in cerebral ischemia. However, it cannot transverse blood brain barrier (BBB) due to its large size. A protein transduction domain (PTD) of HIV TAT protein, is capable of delivering a large variety of proteins into the brain. In this study, we generated a fusion protein TAT-14-3-3 epsilon, and evaluated its potential neuroprotective effect in rat focal ischemia/reperfusion (I/R) model. Western blot analysis validated the efficient transduction of TAT-14-3-3 epsilon fusion protein into brain via a route of intravenous injection. TAT-14-3-3 epsilon pre-treatment 2 h before ischemia significantly reduced cerebral infarction volume and improved neurologic score, while post-treatment 2 h after ischemia was less effective. Importantly, pre- or post-ischemic treatment with TAT-14-3-3 epsilon significantly increased the number of surviving neurons as determined by Nissl staining, and attenuated I/R-induced neuronal apoptosis as showed by the decrease in apoptotic cell numbers and the inhibition of caspase-3 activity. Moreover, the introduction of 14-3-3 epsilon into brain by TAT-mediated delivering reduced the formation of autophagosome, attenuated LC3B-II upregulation and reversed p62 downregulation induced by ischemic injury. Such inhibition of autophagy was reversed by treatment with an autophagy inducer rapamycin (RAP), which also attenuated the neuroprotective effect of TAT-14-3-3 epsilon. Conversely, autophagy inhibitor 3-methyladenine (3-MA) inhibited I/R-induced the increase in autophagic activity, and attenuated I/R-induced brain infarct. These results suggest that TAT-14-3-3 epsilon can be efficiently transduced into brain and exert significantly protective effect against brain ischemic injury through inhibiting neuronal apoptosis and autophagic activation.

TAT Protein Transduction Domain-Mediated the BCR/ABL Fusion Protein Passing Through the Blood-Brain Barrier of the Mouse in Vivo

TAT Protein Transduction Domain Mediates Transmembrane Delivery of BCR/ABL Fusion Protein into Tissue Cells of Mice in Vivo

TAT Protein Transduction Domain Mediates Transmembrane Delivery of EGFP into Tissue Cells of Mice in Vivo

Construction of Vector Ptat-Bdnf and Expression of Fusion Protein

Bcl-2 Gene Therapy for Apoptosis Following Traumatic Brain Injury.

Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency

TAT-Mediated Transmembrane Delivery of Fusion Protein into Different Organs and Skin in Mice

[Neuroprotection of a Neotype Transactivating-Brain-derived Neurotrophic Factor Fusion Protein with Penetrating Activity of Blood-Brain Barrier].

Purification,Expression and Verification of PTD-Lmp-3 Fusion Protein

In VivoDelivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects Against Ischemic Brain Injury and Neuronal Apoptosis

TAT-mediated Delivery of Neuroglobin Protects Against Focal Cerebral Ischemia in Mice

The TAT Peptide Endows PACAP with an Enhanced Ability to Traverse Bio-Barriers

Possible Mecanism of Transmembrane of TAT-PTD Fusion Protein

Neuroprotective Effect of TAT-14-3-3ε Fusion Protein against Cerebral Ischemia/Reperfusion Injury in Rats

HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors.

Fusion protein containing SH3 domain of c-Abl induces hepatocarcinoma cells to apoptosis

Intravenous Injection of Fusion Protein TAT-BDNF Relieves Acute Spinal Cord Injury in Rats

Cloning,expression and activity anaylsis of cell-penetrating peptide TAT

The HIV Tat protein transduction domain improves the biodistribution of β-glucuronidase expressed from recombinant viral vectors

Neuroprotective Effect Of Tat-14-3-3 Epsilon Fusion Protein Against Cerebral Ischemia/Reperfusion Injury In Rats

The Transmembrane Activity of the PTD of Tat Protein Fused at the Carboxyl - Terminus of GFP in Vivo